Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.

Autor: Greiner G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Ihr Labor, Medical Diagnostic Laboratories, Vienna, Austria.; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Witzeneder N; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Klein K; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria., Tangermann S; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria., Kodajova P; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria., Jaeger E; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Ratzinger F; Ihr Labor, Medical Diagnostic Laboratories, Vienna, Austria., Gerner MC; Division of Biomedical Science, University of Applied Sciences FH Campus Wien, Vienna, Austria., Jawhar M; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.; Department of Hematology and Oncology, Helios Pforzheim, Pforzheim, Germany., Baumgartner S; Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Vienna, Austria., Fruehwirth K; Medical Central Laboratory, State Hospital Feldkirch, Feldkirch, Austria., Schmetterer KG; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Zuber J; Research Institute of Molecular Pathology, Vienna Biocenter, Vienna, Austria., Gleixner KV; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Mayerhofer M; Ihr Labor, Medical Diagnostic Laboratories, Vienna, Austria., Schwarzinger I; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Simonitsch-Klupp I; Department of Pathology, Medical University of Vienna, Vienna, Austria., Esterbauer H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Baer C; Munich Leukemia Laboratory, Munich, Germany., Walter W; Munich Leukemia Laboratory, Munich, Germany., Meggendorfer M; Munich Leukemia Laboratory, Munich, Germany., Strassl R; Division of Clinical Virology, Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Haferlach T; Munich Leukemia Laboratory, Munich, Germany., Hartmann K; Division of Allergy, Department of Dermatology, University Hospital Basel and University of Basel, Basel, Switzerland.; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland., Kenner L; Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria.; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria.; Center for Biomarker Research in Medicine, Graz, Austria., Sperr WR; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany., Sexl V; University of Innsbruck, Innsbruck, Austria., Arock M; Department of Hematological Biology and French National Reference Center for Mastocytosis (CEREMAST), Pitié-Salpêtrière Hospital, Paris Sorbonne University, Paris, France., Valent P; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Hoermann G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.; Munich Leukemia Laboratory, Munich, Germany.

Publikováno v: Blood [Blood] 2024 Mar 14; Vol. 143 (11), pp. 1006-1017.

Prognostic significance of serial determinations of lactate dehydrogenase (LDH) in the follow-up of patients with myelodysplastic syndromes

Autor: Wimazal, F., Sperr, W.R., Kundi, M., Vales, A., Fonatsch, C., Thalhammer-Scherrer, R., Schwarzinger, I., Valent, P. ^*

Publikováno v: In Annals of Oncology May 2008 19(5):970-976

Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.

Autor: Füreder, Wolfgang, Sperr, W. R., Heibl, S., Zebisch, A., Pfeilstöcker, M., Stefanzl, G., Jäger, E., Greiner, G., Schwarzinger, I., Kundi, M., Keil, F., Hoermann, G., Bettelheim, P., Valent, P.

Publikováno v: Annals of Hematology; Oct2020, Vol. 99 Issue 10, p2303-2313, 11p

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Autor: Kornauth C; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center Vienna, Medical University of Vienna and Vienna General Hospital, Vienna, Austria., Pemovska T; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Vladimer GI; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Exscientia GmbH, Vienna, Austria., Bayer G; Department of Pathology, Medical University of Vienna, Vienna, Austria., Bergmann M; Department of Surgery, Medical University of Vienna, Vienna, Austria., Eder S; Department of Internal Medicine and Hematology/Oncology, Klinikum Klagenfurt, Klagenfurt, Austria., Eichner R; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Erl M; Abteilung für Innere Medizin, Krankenhaus der Barmherzigen Brüder Salzburg, Salzburg, Austria., Esterbauer H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Exner R; Department of Surgery, Medical University of Vienna, Vienna, Austria., Felsleitner-Hauer V; Department of Medicine and Oncology, LKH Wiener Neustadt, Wiener Neustadt, Austria., Forte M; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Gaiger A; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center Vienna, Medical University of Vienna and Vienna General Hospital, Vienna, Austria., Geissler K; Medical School, Sigmund Freud University, Vienna, Austria., Greinix HT; Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria., Gstöttner W; Department of Otorhinolaryngology, Head and Neck Surgery, Medical University of Vienna, Vienna, Austria., Hacker M; Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Hartmann BL; Landeskrankenhaus Feldkirch, Abteilung für Innere Medizin, Feldkirch, Austria., Hauswirth AW; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Heinemann T; Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich, Switzerland., Heintel D; Division of Medicine I, Klinik Ottakring, Vienna, Austria., Hoda MA; Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria., Hopfinger G; Third Medical Department, Centre for Oncology and Haematology, Klinik Favoriten, Vienna, Austria., Jaeger U; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center Vienna, Medical University of Vienna and Vienna General Hospital, Vienna, Austria., Kazianka L; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Kenner L; Department of Pathology, Medical University of Vienna, Vienna, Austria., Kiesewetter B; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Krall N; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Exscientia GmbH, Vienna, Austria., Krajnik G; Department of Medicine I, Universitätsklinikum St. Pölten, St. Pölten, Austria., Kubicek S; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Le T; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Lubowitzki S; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Mayerhoefer ME; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Menschel E; Third Medical Department, Hematology & Oncology, Hanusch Hospital, Vienna, Austria., Merkel O; Department of Pathology, Medical University of Vienna, Vienna, Austria., Miura K; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan., Müllauer L; Department of Pathology, Medical University of Vienna, Vienna, Austria., Neumeister P; Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria., Noesslinger T; Third Medical Department, Hematology & Oncology, Hanusch Hospital, Vienna, Austria., Ocko K; Pharmacy Department, Vienna General Hospital, Vienna, Austria., Öhler L; Internal Medicine I, Department of Oncology, St. Josef Hospital, Vienna, Austria., Panny M; Third Medical Department, Hematology & Oncology, Hanusch Hospital, Vienna, Austria., Pichler A; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Porpaczy E; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Prager GW; Comprehensive Cancer Center Vienna, Medical University of Vienna and Vienna General Hospital, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Raderer M; Comprehensive Cancer Center Vienna, Medical University of Vienna and Vienna General Hospital, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Ristl R; Section for Medical Statistics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria., Ruckser R; Second Medical Department, Klinik Donaustadt, Vienna, Austria., Salamon J; Department of Medicine, Landesklinikum Waidhofen a.d. Ybbs, Waidhofen-Ybbs, Austria., Schiefer AI; Department of Pathology, Medical University of Vienna, Vienna, Austria., Schmolke AS; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Schwarzinger I; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Selzer E; Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria., Sillaber C; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Skrabs C; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Sperr WR; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Srndic I; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Thalhammer R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Valent P; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., van der Kouwe E; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Vanura K; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria., Vogt S; Department of Medicine and Oncology, LKH Wiener Neustadt, Wiener Neustadt, Austria., Waldstein C; Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria., Wolf D; Department of Internal Medicine V, Department of Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria., Zielinski CC; Vienna Cancer Center, Medical University of Vienna, Vienna, Austria., Zojer N; Division of Medicine I, Klinik Ottakring, Vienna, Austria., Simonitsch-Klupp I; Department of Pathology, Medical University of Vienna, Vienna, Austria., Superti-Furga G; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria., Snijder B; Department of Biology, Institute of Molecular Systems Biology, ETH Zürich, Zürich, Switzerland., Staber PB; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria. philipp.staber@meduniwien.ac.at.; Comprehensive Cancer Center Vienna, Medical University of Vienna and Vienna General Hospital, Vienna, Austria.

Publikováno v: Cancer discovery [Cancer Discov] 2022 Feb; Vol. 12 (2), pp. 372-387. Date of Electronic Publication: 2021 Oct 11.

Adequate scattergram interpretation increases the reliability of automated polymorphonuclear (pmn) cell counts from ascitic fluid of patients with liver cirrhosis.

Autor: Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Rappel R; Sysmex Austria, Vienna, Austria., Thalhammer R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Demyanets S; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Simbrunner B; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria., Reiberger T; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, Vienna, Austria., Eberhard S; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Schwarzinger I; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

Publikováno v: International journal of laboratory hematology [Int J Lab Hematol] 2021 Aug; Vol. 43 (4), pp. O176-O180. Date of Electronic Publication: 2021 Feb 19.